Friday, October 2, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 23, 2026

AS-i Harju Elekter Group majandustulemused, 1-6/2026

View original at globenewswire.com
“Ärikasum enne kulumit (EBITDA) 2 266 4 658 -51,4% 3 905 8 523 -54,2%”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q2 and H1 2026 results fell significantly short of both revenue and profit targets due to lower-than-expected sales volume and part of revenue shifting to future periods

    60% confidence

  • In Sweden, long-execution-time projects make up a significant share of the order book, with realization extending into 2028

    60% confidence

  • 2026 is considered a transition year during which the company prepares for the next high-activity periods, with a stronger order book for H2 than H1

    60% confidence

  • Ongoing preparations and a growing order book create the conditions for servicing larger project volumes and for revenue and profitability growth in future years

    60% confidence

  • The Estonian local distribution grid operator has reduced its investment volumes, weighing on the local market

    60% confidence

Data points we hold from this source

Harju Elekter Group · net income0.272 USD
Harju Elekter Group · labor costs21.4 USD
Harju Elekter Group · margin12.2 percent
Harju Elekter Group · long term financial investments27.223 USD
Harju Elekter Group · labor cost ratio27.7 percent
Harju Elekter Group · capital expenditure3.9 USD
Harju Elekter Group · admin expenses5.627 USD
Harju Elekter Group · admin expense ratio7.3 percent
Harju Elekter Group · employee wage costs16.7 USD
Harju Elekter Group · ebit margin2.6 percent
Harju Elekter Group · debt35.467 USD
Harju Elekter Group · inventory20.456 USD
Harju Elekter Group · equity95.155 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com